These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 19719752

  • 1. B-type natriuretic peptide attenuates cardiac hypertrophy via the transforming growth factor-ß1/smad7 pathway in vivo and in vitro.
    He JG, Chen YL, Chen BL, Huang YY, Yao FJ, Chen SL, Dong YG.
    Clin Exp Pharmacol Physiol; 2010 Mar; 37(3):283-9. PubMed ID: 19719752
    [Abstract] [Full Text] [Related]

  • 2. Effect of long-term B-type natriuretic peptide treatment on left ventricular remodeling and function after myocardial infarction in rats.
    He J, Chen Y, Huang Y, Yao F, Wu Z, Chen S, Wang L, Xiao P, Dai G, Meng R, Zhang C, Tang L, Huang Y, Li Z.
    Eur J Pharmacol; 2009 Jan 05; 602(1):132-7. PubMed ID: 19027731
    [Abstract] [Full Text] [Related]

  • 3. Fluvastatin decreases cardiac fibrosis possibly through regulation of TGF-beta(1)/Smad 7 expression in the spontaneously hypertensive rats.
    Zhai Y, Gao X, Wu Q, Peng L, Lin J, Zuo Z.
    Eur J Pharmacol; 2008 Jun 10; 587(1-3):196-203. PubMed ID: 18430418
    [Abstract] [Full Text] [Related]

  • 4. Endogenous BNP attenuates cardiomyocyte hypertrophy induced by Ang II via p38 MAPK/Smad signaling.
    Chen Y, Yao F, Chen S, Huang H, Wu L, He J, Dong Y.
    Pharmazie; 2014 Nov 10; 69(11):833-7. PubMed ID: 25985580
    [Abstract] [Full Text] [Related]

  • 5. Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats.
    Zhang CX, Pan SN, Meng RS, Peng CQ, Xiong ZJ, Chen BL, Chen GQ, Yao FJ, Chen YL, Ma YD, Dong YG.
    Clin Exp Pharmacol Physiol; 2011 Jan 10; 38(1):55-62. PubMed ID: 21083698
    [Abstract] [Full Text] [Related]

  • 6. [Effect of Smad7 on transforming growth factor-beta1-induced alveolar epithelial to mesenchymal transition].
    Xu GP, Li QQ, Cao XX, Chen Q, Zhao ZH, Diao ZQ, Xu ZD.
    Zhonghua Yi Xue Za Zhi; 2007 Jul 17; 87(27):1918-23. PubMed ID: 17923018
    [Abstract] [Full Text] [Related]

  • 7. Erythropoietin attenuates hypertrophy of neonatal rat cardiac myocytes induced by angiotensin-II in vitro.
    Wen Y, Zhang XJ, Ma YX, Xu XJ, Hong LF, Lu ZH.
    Scand J Clin Lab Invest; 2009 Jul 17; 69(4):518-25. PubMed ID: 19347742
    [Abstract] [Full Text] [Related]

  • 8. IGF-II/mannose-6-phosphate receptor signaling induced cell hypertrophy and atrial natriuretic peptide/BNP expression via Galphaq interaction and protein kinase C-alpha/CaMKII activation in H9c2 cardiomyoblast cells.
    Chu CH, Tzang BS, Chen LM, Kuo CH, Cheng YC, Chen LY, Tsai FJ, Tsai CH, Kuo WW, Huang CY.
    J Endocrinol; 2008 May 17; 197(2):381-90. PubMed ID: 18434368
    [Abstract] [Full Text] [Related]

  • 9. G(alphaq)-protein carboxyl terminus imitation polypeptide GCIP-27 attenuates cardiac hypertrophy in vitro and in vivo.
    Zhang HG, Li XH, Zhou JZ, Liu Y, Jia Y, Yuan ZB.
    Clin Exp Pharmacol Physiol; 2007 Dec 17; 34(12):1276-81. PubMed ID: 17973867
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced cardiac hypertrophy and fibrosis in vivo.
    Yang J, Zhu HH, Chen GP, Ye Y, Zhao CZ, Mou Y, Hu SJ.
    Int J Biochem Cell Biol; 2013 Mar 17; 45(3):657-66. PubMed ID: 23277274
    [Abstract] [Full Text] [Related]

  • 11. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload.
    Nakagawa O, Ogawa Y, Itoh H, Suga S, Komatsu Y, Kishimoto I, Nishino K, Yoshimasa T, Nakao K.
    J Clin Invest; 1995 Sep 17; 96(3):1280-7. PubMed ID: 7657802
    [Abstract] [Full Text] [Related]

  • 12. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y, Asakura M, Takashima S, Ogai A, Asano Y, Shintani Y, Minamino T, Asanuma H, Sanada S, Kim J, Kitamura S, Tomoike H, Hori M, Kitakaze M.
    Circulation; 2004 Aug 10; 110(6):692-9. PubMed ID: 15262839
    [Abstract] [Full Text] [Related]

  • 13. Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy.
    Li HL, Yin R, Chen D, Liu D, Wang D, Yang Q, Dong YG.
    J Cell Biochem; 2007 Apr 01; 100(5):1086-99. PubMed ID: 17266062
    [Abstract] [Full Text] [Related]

  • 14. [Activation of transforming growth factor-beta1/Smads signal pathway in diabetic cardiomyopathy and effects of valsartan thereon: experiment with rats].
    Miao Y, Zhang W, Zhong M, Ma X, Qi TG, Sun H.
    Zhonghua Yi Xue Za Zhi; 2007 Feb 06; 87(6):366-70. PubMed ID: 17456374
    [Abstract] [Full Text] [Related]

  • 15. Atrial natriuretic peptide inhibits cardiomyocyte hypertrophy through mitogen-activated protein kinase phosphatase-1.
    Hayashi D, Kudoh S, Shiojima I, Zou Y, Harada K, Shimoyama M, Imai Y, Monzen K, Yamazaki T, Yazaki Y, Nagai R, Komuro I.
    Biochem Biophys Res Commun; 2004 Sep 10; 322(1):310-9. PubMed ID: 15313208
    [Abstract] [Full Text] [Related]

  • 16. Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level.
    Feng B, Chen S, Chiu J, George B, Chakrabarti S.
    Am J Physiol Endocrinol Metab; 2008 Jun 10; 294(6):E1119-26. PubMed ID: 18413674
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Transforming growth factor-beta signaling enhances transdifferentiation of macrophages into smooth muscle-like cells.
    Ninomiya K, Takahashi A, Fujioka Y, Ishikawa Y, Yokoyama M.
    Hypertens Res; 2006 Apr 10; 29(4):269-76. PubMed ID: 16778334
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effects of different immunosuppressants on chronic allograft nephropathy by affecting the transforming growth factor-beta and Smads signal pathways.
    Gao R, Lu Y, Xin YP, Zhang XH, Wang J, Li YP.
    Transplant Proc; 2006 Sep 10; 38(7):2154-7. PubMed ID: 16980029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.